Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.
Content
Multiple Myeloma
6m 20s
Selecting Multiple Myeloma treatment based on frailty status
Published 11 Jul 2022
Elderly patients can be stratified into Very Fit , Fit and Unfit patients based on validated scales. There are some clinical trials which are evaluating frailty adjusted therapy in Multiple Myeloma. This is another step-in individualizing treatment options for elderly patients.